USFDA approves Phase 3 Acute Respiratory Distress Syndrome (ARDS), trial
The Phase 3 trial will be conducted under the auspices of the first Regenerative Medicine Advanced Therapy (RMAT) designation approved by the USFDA for an EV therapeutic
The Phase 3 trial will be conducted under the auspices of the first Regenerative Medicine Advanced Therapy (RMAT) designation approved by the USFDA for an EV therapeutic
Fujifilm’s NEVER STOP philosophy to enhance the access to healthcare for all Indians
The DalPhos ligands were developed by Prof. Mark Stradiotto and his research team at the Department of Chemistry, Dalhousie University
An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa Capsules of Boehringer lngelheim
Makrolon polycarbonate is key to needle-free injections that can stand up to sterilization
Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 clinical trial in adult patients with moderate-to-severe Covid-19
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
Subscribe To Our Newsletter & Stay Updated